News MIPLYFFA™ September 20, 2024 Read More » Bionpharma Inc. Issues Voluntary Nationwide Recall of Atovaquone OralSuspension Due to Bacterial Contamination September 17, 2024 Read More » OCREVUS ZUNOVO September 13, 2024 Read More » EBGLYSS September 13, 2024 Read More » ENZEEVU September 12, 2024 Read More » TECENTRIQ HYBREZA September 12, 2024 Read More » Gilead Issues Voluntary Nationwide Recall of One Lot of Veklury (Remdesivir) forInjection 100mg/vial Due to the Presence of a Glass Particle September 10, 2024 Read More » BORUZU September 5, 2024 Read More » GENERIC DRUG APPROVALS September 1, 2024 Read More » Page1 Page2 Page3 Page4 Page5 … Page41 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required)Email(Required) Comment(Required)Company Name(Required)CAPTCHA
Bionpharma Inc. Issues Voluntary Nationwide Recall of Atovaquone OralSuspension Due to Bacterial Contamination September 17, 2024 Read More »
Gilead Issues Voluntary Nationwide Recall of One Lot of Veklury (Remdesivir) forInjection 100mg/vial Due to the Presence of a Glass Particle September 10, 2024 Read More »